7/1/2009 through 6/30/2012

Researchers Study New Treatment for Triple-Negative Metastatic Breast Cancer

New phase III trial studies BSI-201 added to chemotherapy for triple-negative metastatic breast cancers. Read more ...

1/30/2008

Trial Compares Standard Chemotherapy Schedules

Phase III study compares four versus six courses of AC chemotherapy versus T alone given every two weeks for early-stage breast cancer. Read more ...

6/1/2007

Trial Examines Optimal Treatments for HER2-Positive Early Breast Cancer

Phase III trial will compare lapatinib and trastuzumab in preventing recurrence of early-stage breast cancer after surgery and chemotherapy. Read more ...

6/1/2007 through 6/1/2014

Researchers Test Safety and Effectiveness of New Advanced Breast Cancer Treatment

Phase II trial will compare paclitaxel plus sorafenib to paclitaxel alone in women with locally recurrent or metastatic breast cancer Read more ...

10/1/2006

Trial Examines Value of Circulating Cancer Cells in Advanced Cancer

Trial studies whether women with high levels of circulating tumor cells who switch medicines after their first chemotherapy treatment live longer than those who do not Read more ...

8/1/2006

Sexual Well-Being and Breast Cancer Study for Women who Partner with Women

Boston University researchers seek lesbians, bisexual women and women who partner with women who have or have not had breast cancer to complete a survey about sexual well-being Read more ...

Ongoing

Trial for Young Women Studies Effectiveness of Goserelin to Prevent Early Menopause

A randomized phase III clinical trial for young women with stage I-IIIA hormone receptor-negative breast cancer compares the effectiveness of ovarian suppression using goserelin combined with chemotherapy versus chemotherapy alone in preventing early menopause. Read more ...